Although several studies have proposed numerous biomarkers for predicting the efficacy of a treatment such as the expression of PD-L1, TMB, and microsatellite instability (MSI) biomarkers, most of these markers focus on the tumor invasion of the lymphocyte or TME. The gene discussed is CD274; the disease is neoplasm.